Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vaxol
- Development stage
- Unknown
- Lead developer
- Farmasyn
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Vaxol is a topical ear spray developed and distributed by Farmasyn, primarily used for the softening and removal of earwax and the protection of the ear canal. Its formulation consists of pharmaceutically purified olive oil and mineral oil. The product works by lubricating and moisturizing the ear canal skin, which helps relieve itching and irritation while creating a protective barrier against water. It utilizes a "fat dissolves fat" mechanism to break down earwax. Vaxol is intended for use in adults and children over one year of age and features a metered-dose delivery system for precise application into the outer ear.
- Brand names
- Vaxol
- Other names
- Vaxol Ear Spray
02
Targets
PDE3
Beyond the preview
Go deeper on Vaxol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vaxol.